What Happened? A number of stocks jumped in the afternoon session after cooler-than-expected inflation data ignited investor ...

What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest ...

Nyxoah SA (NASDAQ:NYXH) saw its stock rise 9.4% after the FDA granted approval for its Genio system designed to treat ...

Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP ...

IO Biotech (IOBT) stock rallies as cancer vaccine, Cylembio, with Merck's (MRK) Keytruda outperforms in a late-stage trial ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at senior health, home health & hospice ...

Q2 2025 earnings highlights: record revenue growth, strategic updates, and raised guidance amidst tariff challenges.

UnitedHealth will divest 164 healthcare locations and Amedisys will pay a $1.1 million penalty under a DOJ settlement ...

Orchestra BioMed (NASDAQ:OBIO) stock gains as the FDA-approved protocol update expands its pivotal BACKBEAT study for its ...

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...